Regenxbio’s Triple Threat: Partnered Programs, DMD Progress And In-House Manufacturing

 
• By David Wild
  
Regenxbio
• Source: Alamy
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from C-Suite Speaks

More from Market Access